WD Rutherford LLC Increases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

WD Rutherford LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 168.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,135 shares of the company's stock after purchasing an additional 13,249 shares during the quarter. WD Rutherford LLC's holdings in GE HealthCare Technologies were worth $1,984,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of GEHC. Avitas Wealth Management LLC lifted its position in GE HealthCare Technologies by 1.5% during the third quarter. Avitas Wealth Management LLC now owns 19,769 shares of the company's stock valued at $1,855,000 after purchasing an additional 300 shares during the period. Valmark Advisers Inc. purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $222,000. Argyle Capital Management Inc. lifted its holdings in shares of GE HealthCare Technologies by 2.7% in the 3rd quarter. Argyle Capital Management Inc. now owns 11,944 shares of the company's stock valued at $1,121,000 after buying an additional 317 shares during the period. China Universal Asset Management Co. Ltd. boosted its stake in shares of GE HealthCare Technologies by 111.1% in the third quarter. China Universal Asset Management Co. Ltd. now owns 5,792 shares of the company's stock worth $544,000 after buying an additional 3,048 shares during the last quarter. Finally, Orrstown Financial Services Inc. acquired a new stake in GE HealthCare Technologies during the third quarter worth about $231,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on GEHC. BTIG Research raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price target for the company in a report on Wednesday, September 18th. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and decreased their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Evercore ISI raised their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research report on Tuesday, October 1st. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a "strong-buy" rating in a research report on Thursday, August 1st. Finally, JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a "neutral" rating and a $90.00 target price on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $94.23.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock traded up $1.41 during mid-day trading on Wednesday, reaching $86.68. 1,845,971 shares of the stock traded hands, compared to its average volume of 2,995,779. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. The business has a 50-day moving average of $88.46 and a 200 day moving average of $83.39. The stock has a market capitalization of $39.57 billion, a PE ratio of 25.35, a PEG ratio of 3.34 and a beta of 1.18. GE HealthCare Technologies Inc. has a fifty-two week low of $65.77 and a fifty-two week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts' consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter last year, the firm posted $0.92 EPS. The firm's revenue for the quarter was up .5% on a year-over-year basis. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies's dividend payout ratio is currently 3.51%.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the firm's stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company's stock, valued at $1,414,377.02. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.